Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Human Pathology|December 4, 2012
Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 casesEsther Oliva, Nathanael F Pinheiro, Niall M Heney, et al.
The Journal of Urology|September 6, 2017
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder CancerAlejandro Sanchez, Matthew F Wszolek, Andrzej Niemierko, et al.
European Urology|November 22, 2011
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experienceJason A Efstathiou, Daphna Y Spiegel, William U Shipley, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2015
Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233Timur Mitin, Asha George, Anthony L Zietman, et al.
European Urology|January 2, 2017
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing TherapyRoss E Krasnow, Michael Drumm, Hannah J Roberts, et al.
European Urology|January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital ExperienceNicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Urologic Oncology|July 7, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01Raymond H Mak, Daniel Hunt, Jason A Efstathiou, et al.
The New England Journal of Medicine|February 2, 2017
Radiation with or without Antiandrogen Therapy in Recurrent Prostate CancerWilliam U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.
Pageof 2